UroGen Pharma (URGN) Receivables (2016 - 2026)
UroGen Pharma (URGN) reported Receivables of $88.76 million for Q2 2026, up 351.7% from $19.65 million a year earlier and up 60.2% from the prior quarter.
Powered by 
Analysis
UroGen Pharma (URGN) Receivables (2016 - 2026) Analysis & Trends
At the end of FY2025, UroGen Pharma posted Receivables of $33.08 million, up 62.9% from FY2024.
- Receivables has increased for five consecutive years, with a five-year compound annual growth rate of 36.2% (FY2020 to FY2025).
- By year, Receivables came in at $20.3 million in FY2024 (+31.5%), $15.44 million in FY2023 (+21.6%), $12.7 million in FY2022 (+8.4%) and $11.72 million in FY2021 (+66.3%).
- The Q2 2026 figure ranks as the highest quarterly Receivables in data going back to Q4 2016.
- Year over year, Receivables has now increased in each of the last three quarters, with growth averaging 93.0% over the last eight quarters.
- The high point for year-over-year Receivables in five years was Q2 2026 (growth of 351.7%); the low point was Q3 2025 (a decline of 13.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $55.41 million (Q1 2026), $33.08 million (Q4 2025) and $19.7 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 2.13 Bn |
| 10 | UroGen Pharma | 1.98 Bn | 1.48 Bn | 65.88 Mn | 88.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 88.76 Mn |
| Mar 31, 2026 | 55.41 Mn |
| Dec 31, 2025 | 33.08 Mn |
| Sep 30, 2025 | 19.70 Mn |
| Jun 30, 2025 | 19.65 Mn |
| Mar 31, 2025 | 19.64 Mn |
| Dec 31, 2024 | 20.30 Mn |
| Sep 30, 2024 | 22.80 Mn |
| Jun 30, 2024 | 17.42 Mn |
| Mar 31, 2024 | 14.16 Mn |
| Dec 31, 2023 | 15.44 Mn |
| Sep 30, 2023 | 12.85 Mn |
| Jun 30, 2023 | 15.51 Mn |
| Mar 31, 2023 | 12.49 Mn |
| Dec 31, 2022 | 12.70 Mn |
| Sep 30, 2022 | 9.43 Mn |
| Jun 30, 2022 | 11.60 Mn |
| Mar 31, 2022 | 9.50 Mn |
| Dec 31, 2021 | 11.72 Mn |
| Sep 30, 2021 | 7.78 Mn |
API Access
UroGen Pharma Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=URGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "URGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=URGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();